General Information of the Compound
| Compound ID |
CP0845135
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1-(4-(1-cyclopentylpiperidin-4-yloxy)phenyl)-4-(3-(methylsulfonyl)benzoyl)piperazin-2-one formic acid
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C29H37N3O7S
|
||||||||||||||||||
| Molecular Weight |
571.696
|
||||||||||||||||||
| Canonical SMILES |
CS(=O)(=O)c1cccc(C(=O)N2CCN(c3ccc(OC4CCN(C5CCCC5)CC4)cc3)C(=O)C2)c1.O=CO
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C28H35N3O5S.CH2O2/c1-37(34,35)26-8-4-5-21(19-26)28(33)30-17-18-31(27(32)20-30)23-9-11-24(12-10-23)36-25-13-15-29(16-14-25)22-6-2-3-7-22;2-1-3/h4-5,8-12,19,22,25H,2-3,6-7,13-18,20H2,1H3;1H,(H,2,3)
Show/Hide
|
||||||||||||||||||
| InChIKey |
QGFBWPZGQZAHLL-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01206, Histamine H1 receptor
Protein ID: PT01194, Histamine H3 receptor
Protein ID: PT00897, Potassium voltage-gated channel subfamily H member 2